[Reduction of the Nordin index after therapy with oral alendronate in patients with postmenopausal osteoporosis].

Abstract

The authors observe a significant reduction in value of the Nordin's Index (a sensible test for the screening of the "fast-losers" patients) in 10 women with post-menopausal osteoporosis after therapy with alendronate 5 mg daily per os for six months. The authors propound the measurement of the Nordin's Index in order to assess the alendronate's therapy per os in the post-menopausal osteoporosis.

• Authors: S Busi, A Catalano
• Journal: La Clinica terapeutica (Clin Ter) Vol. 146 Issue 12 Pg. 857-9 (Dec 1995) ISSN: 0009-9074 [Print] Italy
• Vernacular Title: Riduzione dell'indice di Nordin dopo trattamento con alendronato per os in pazienti con osteoporosi post-menopausale.
• PMID: 8681505 (Publication Type: English Abstract, Journal Article)

Chemical References

• Diphosphonates
• Alendronate

Topics

• Administration, Oral
• Adult
• Aged
• Alendronate
• Bone Density (drug effects)
• Bone Resorption (drug therapy)
• Diphosphonates (administration & dosage, therapeutic use)
• Female
• Humans
• Middle Aged
• Osteoporosis, Postmenopausal (drug therapy)